Genmab A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0010272202
DKK
1,712.50
1376.14 (409.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
5,721.57
6,788.71
6,527.05
6,089.31
5,067.94
6,441.00
5,540.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,721.57
6,788.71
6,527.05
6,089.31
5,067.94
6,441.00
5,540.00
Raw Material Cost
415.07
519.74
370.42
375.23
297.70
337.00
273.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
715.20
282.33
19.16
59.25
35.44
54.00
18.00
Selling and Distribution Expenses
1,060.02
1,334.64
945.21
947.96
893.09
1,249.00
865.00
Other Expenses
209.45
309.28
226.08
233.70
250.92
261.00
226.50
Total Expenditure (Excl Depreciation)
4,284.79
5,229.49
3,595.63
3,719.42
3,735.39
4,250.00
3,421.00
Operating Profit (PBDIT) excl Other Income
1436.8000000000002
1559.1999999999998
2931.3999999999996
2369.9
1332.5
2191
2119
Other Income
38.31
263.08
166.05
473.98
432.37
1,496.00
-365.00
Operating Profit (PBDIT)
1,475.09
1,822.30
3,097.48
2,843.87
1,764.92
3,687.00
1,754.00
Interest
715.20
282.33
19.16
59.25
35.44
54.00
18.00
Exceptional Items
-287.36
-1,187.06
0.00
0.00
0.00
-31.00
-17.00
Gross Profit (PBDT)
5,306.50
6,268.97
6,156.63
5,714.08
4,770.24
6,104.00
5,267.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
472.54
352.91
3,078.32
2,784.63
1,729.48
3,602.00
1,719.00
Tax
134.10
154.00
517.31
572.72
347.31
-243.00
453.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
338.44
198.91
2,561.01
2,211.90
1,382.17
3,845.00
1,266.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
338.44
198.91
2,561.01
2,211.90
1,382.17
3,845.00
1,266.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
338.44
198.91
2,561.01
2,211.90
1,382.17
3,845.00
1,266.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
6.36
0.0
1.0
1.0
Reserves
36,850.04
37,184.58
36,534.95
33,698.45
36,577.88
36,697.00
31,922.00
Earnings per share (EPS)
5.3
2.96
41.26
35.96
21.62
59.64
19.81
Diluted Earnings per share
5.3
2.96
41.26
35.96
21.62
59.64
19.81
Operating Profit Margin (Excl OI)
25.11%
22.97%
44.91%
38.92%
26.29%
34.02%
38.25%
Gross Profit Margin
8.26%
5.2%
47.16%
45.73%
34.13%
55.92%
31.03%
PAT Margin
5.92%
2.93%
39.24%
36.32%
27.27%
59.7%
22.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 12.90% vs 22.32% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -75.52% vs 4.32% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 7.83% vs 66.35% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 1,920.34% vs 405.71% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Genmab A/S With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Net Sales
5,721.57
96,823.00
-91,101.43
-94.09%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,721.57
96,823.00
-91,101.43
-94.09%
Raw Material Cost
415.07
13,598.00
-13,182.93
-96.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
715.20
3,499.00
-2,783.80
-79.56%
Selling and Distribution Expenses
1,060.02
13,194.00
-12,133.98
-91.97%
Other Expenses
209.45
678.50
-469.05
-69.13%
Total Expenditure (Excl Depreciation)
4,284.79
37,076.00
-32,791.21
-88.44%
Operating Profit (PBDIT) excl Other Income
1,436.78
59,747.00
-58,310.22
-97.60%
Other Income
38.31
5,947.00
-5,908.69
-99.36%
Operating Profit (PBDIT)
1,475.09
69,207.00
-67,731.91
-97.87%
Interest
715.20
3,499.00
-2,783.80
-79.56%
Exceptional Items
-287.36
-23.00
-264.36
-1,149.39%
Gross Profit (PBDT)
5,306.50
83,225.00
-77,918.50
-93.62%
Depreciation
0.00
3,513.00
-3,513.00
-100.00%
Profit Before Tax
472.54
62,172.00
-61,699.46
-99.24%
Tax
134.10
13,615.00
-13,480.90
-99.02%
Provisions and contingencies
0
0
0.00
Profit After Tax
338.44
48,557.00
-48,218.56
-99.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
338.44
48,557.00
-48,218.56
-99.30%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
338.44
48,557.00
-48,218.56
-99.30%
Equity Capital
0
0
0.00
Face Value
0.00
0.10
0.00
Reserves
36,850.04
2,03,065.00
-1,66,214.96
-81.85%
Earnings per share (EPS)
5.30
10.91
-5.61
-51.42%
Diluted Earnings per share
5.30
10.91
-5.61
-51.42%
Operating Profit Margin (Excl OI)
25.11%
61.71%
0.00
-36.60%
Gross Profit Margin
8.26%
67.84%
0.00
-59.58%
PAT Margin
5.92%
50.15%
0.00
-44.23%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 572.16 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -15.72% vs 4.01% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.90% vs 22.32% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 33.84 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 70.14% vs -92.23% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -75.52% vs 4.32% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 143.68 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -7.85% vs -46.81% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.83% vs 66.35% in Mar 2025

Quarterly - Interest
Interest 71.52 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 153.35% vs 1,370.31% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1,920.34% vs 405.71% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.11%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025